D
NeuPath Health Inc.
NPTH.V
TSX
D
Sell
2/7/2025Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to D- from E+ on 2/7/2025 due to an increase in the volatility index and total return index.
NeuPath Health Inc. (NPTH.V) was upgraded to D- from E+ on 2/7/2025 due to an increase in the volatility index and total return index.
E
Sell
1/23/2025Downgrade
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D- on 1/23/2025 due to a decline in the volatility index.
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D- on 1/23/2025 due to a decline in the volatility index.
D
Sell
1/8/2025Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to D- from E+ on 1/8/2025 due to a significant increase in the total return index, solvency index and volatility index.
NeuPath Health Inc. (NPTH.V) was upgraded to D- from E+ on 1/8/2025 due to a significant increase in the total return index, solvency index and volatility index.
E
Sell
3/14/2023Downgrade
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
NeuPath Health Inc. (NPTH.V) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D- on 02/08/2023.
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D- on 02/08/2023.
D
Sell
1/24/2023Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to D- from E+ on 1/24/2023 due to an increase in the volatility index, total return index and valuation index.
NeuPath Health Inc. (NPTH.V) was upgraded to D- from E+ on 1/24/2023 due to an increase in the volatility index, total return index and valuation index.
E
Sell
1/9/2023Downgrade
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D- on 1/9/2023 due to a noticeable decline in the solvency index, growth index and volatility index. EBIT declined 362.36% from -$73.6 to -$340.3, earnings per share declined from -$0.0057 to -$0.0165, and operating cash flow declined 150.93% from $96.4 to -$49.1.
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D- on 1/9/2023 due to a noticeable decline in the solvency index, growth index and volatility index. EBIT declined 362.36% from -$73.6 to -$340.3, earnings per share declined from -$0.0057 to -$0.0165, and operating cash flow declined 150.93% from $96.4 to -$49.1.
D
Sell
10/21/2022Downgrade
NeuPath Health Inc. (NPTH.V) was downgraded to D- from D on 10/21/2022 due to a decline in the volatility index and total return index.
NeuPath Health Inc. (NPTH.V) was downgraded to D- from D on 10/21/2022 due to a decline in the volatility index and total return index.
D
Sell
10/6/2022Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to D from D- on 10/6/2022 due to an increase in the volatility index, valuation index and total return index.
NeuPath Health Inc. (NPTH.V) was upgraded to D from D- on 10/6/2022 due to an increase in the volatility index, valuation index and total return index.
D
Sell
9/7/2022Downgrade
NeuPath Health Inc. (NPTH.V) was downgraded to D- from D on 9/7/2022 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.96 to 0.81.
NeuPath Health Inc. (NPTH.V) was downgraded to D- from D on 9/7/2022 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.96 to 0.81.
D
Sell
5/16/2022Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
NeuPath Health Inc. (NPTH.V) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell
5/4/2022Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
NeuPath Health Inc. (NPTH.V) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
E
Sell
5/1/2022Downgrade
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D on 05/01/2022.
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D on 05/01/2022.
D
Sell
4/21/2022Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to D from E+ on 04/21/2022.
NeuPath Health Inc. (NPTH.V) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D on 4/20/2022 due to a decline in the total return index.
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D on 4/20/2022 due to a decline in the total return index.
D
Sell
11/9/2021Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to D from E+ on 11/09/2021.
NeuPath Health Inc. (NPTH.V) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D on 11/8/2021 due to a noticeable decline in the solvency index, growth index and volatility index. EBIT declined 1,442.03% from $39.5 to -$530.1, operating cash flow declined 262.58% from $194.3 to -$315.9, and earnings per share declined from -$0.0129 to -$0.0207.
NeuPath Health Inc. (NPTH.V) was downgraded to E+ from D on 11/8/2021 due to a noticeable decline in the solvency index, growth index and volatility index. EBIT declined 1,442.03% from $39.5 to -$530.1, operating cash flow declined 262.58% from $194.3 to -$315.9, and earnings per share declined from -$0.0129 to -$0.0207.
D
Sell
8/2/2021Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to D from D- on 8/2/2021 due to an increase in the valuation index, growth index and solvency index. Operating cash flow increased 119.28% from -$1.01M to $194.3, EBIT increased 107.77% from -$508.6 to $39.5, and debt to equity declined from 0.32 to 0.27.
NeuPath Health Inc. (NPTH.V) was upgraded to D from D- on 8/2/2021 due to an increase in the valuation index, growth index and solvency index. Operating cash flow increased 119.28% from -$1.01M to $194.3, EBIT increased 107.77% from -$508.6 to $39.5, and debt to equity declined from 0.32 to 0.27.
D
Sell
4/1/2021Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to D- from E on 4/1/2021 due to a noticeable increase in the solvency index. The quick ratio increased from 0.85 to 1.87, and debt to equity declined from 0.54 to 0.19.
NeuPath Health Inc. (NPTH.V) was upgraded to D- from E on 4/1/2021 due to a noticeable increase in the solvency index. The quick ratio increased from 0.85 to 1.87, and debt to equity declined from 0.54 to 0.19.
E
Sell
3/3/2021Downgrade
NeuPath Health Inc. (NPTH.V) was downgraded to E from E+ on 3/3/2021 due to a decline in the volatility index and total return index.
NeuPath Health Inc. (NPTH.V) was downgraded to E from E+ on 3/3/2021 due to a decline in the volatility index and total return index.
E
Sell
2/16/2021Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to E+ from E on 2/16/2021 due to an increase in the volatility index.
NeuPath Health Inc. (NPTH.V) was upgraded to E+ from E on 2/16/2021 due to an increase in the volatility index.
E
Sell
1/28/2021Downgrade
NeuPath Health Inc. (NPTH.V) was downgraded to E from E+ on 1/28/2021 due to a decline in the volatility index and total return index.
NeuPath Health Inc. (NPTH.V) was downgraded to E from E+ on 1/28/2021 due to a decline in the volatility index and total return index.
E
Sell
1/4/2021Upgraded
NeuPath Health Inc. (NPTH.V) was upgraded to E+ from E on 1/4/2021 due to a major increase in the growth index, total return index and solvency index. EBIT increased 166.04% from -$47.7 to $31.5, earnings per share increased from -$0.1321 to -$0.0076, and total revenue increased 11.23% from $8.1M to $9.01M.
NeuPath Health Inc. (NPTH.V) was upgraded to E+ from E on 1/4/2021 due to a major increase in the growth index, total return index and solvency index. EBIT increased 166.04% from -$47.7 to $31.5, earnings per share increased from -$0.1321 to -$0.0076, and total revenue increased 11.23% from $8.1M to $9.01M.
E
Sell
9/28/2020None
NeuPath Health Inc. (NPTH.V) was downgraded to E from U on 09/28/2020.
NeuPath Health Inc. (NPTH.V) was downgraded to E from U on 09/28/2020.
